.

Pharmaceutical Business Intelligence

  • Anticipate P&T budget requirements
  • Evaluate market entry opportunities
  • Find generic sources and suppliers
  • Predict branded drug patent expiration

► Plans and Pricing

Upgrade to enjoy subscriber-only features like email alerts and data export. See the Plans and Pricing

DrugPatentWatch Database Preview

Theophylline - Generic Drug Details

« Back to Dashboard
Theophylline is the generic ingredient in fifty-two branded drugs marketed by Nostrum Labs Inc, Alpharma Us Pharms, Forest Labs, Sanofi Aventis Us, Cenci, Ortho Mcneil Pharm, 3M, Pliva, Schering, Hospira Inc, B Braun, Ferndale Labs, Pharm Assoc, Warner Chilcott, Taro, Alembic Ltd, Scherer Rp, Hospira, Auxilium Pharms Inc, Inwood Labs, Teva Pharms, Roxane, Able, Fleming Pharms, Actient Pharms, Auxilium Pharms Llc, Wockhardt, Baxter Hlthcare, Perrigo, Pharm Res Assoc, Cent Pharms, Whitby, Fisons, Glenmark Generics, Silarx, Monarch Pharms, Panray, Mylan Ireland Ltd, Sandoz, Graham Dm, Kv Pharm, Precision Dose, Roerig, Schwarz Pharma, Halsey, Rhodes Pharms, Lannett, Tris Pharma Inc, Medicis, and Novartis, and is included in one hundred and eighteen NDAs. Additional information is available in the individual branded drug profile pages.

There are thirty-six drug master file entries for theophylline. Thirty-two suppliers are listed for this compound.

Summary for Generic Name: theophylline

Tradenames:52
Patents:0
Applicants:50
NDAs:118
Drug Master File Entries: see list36
Suppliers / Packaging: see list32
Therapeutic Class:Respiratory Tract Agents
Formulation / Manufacturing:see details
Drug Prices:see low prices

Pharmacology for Ingredient: theophylline

Ingredient-typeXanthines
Drug ClassMethylxanthine
Applicant Tradename Generic Name Dosage NDA Approval Date Type RLD Patent No. Patent Expiration Product Substance Delist Req. Exclusivity Expiration
Rhodes Pharms
THEOPHYLLINE
theophylline
TABLET, EXTENDED RELEASE;ORAL040086-001Apr 15, 1996RXNo► subscribe► subscribe
Ortho Mcneil Pharm
THEOPHYL-225
theophylline
ELIXIR;ORAL086485-001Approved Prior to Jan 1, 1982DISCNNo► subscribe► subscribe
Fisons
SOMOPHYLLIN-T
theophylline
CAPSULE;ORAL087155-001Feb 25, 1985DISCNNo► subscribe► subscribe
This preview shows a limited data set
Subscribe for full access, or try a Trial

Export unavailable in trial.
Subscribe for complete access.

Expired Orange Book Patents for Generic Ingredient: theophylline

Applicant Tradename Generic Name Dosage NDA Approval Date Patent No. Patent Expiration
Monarch Pharms
QUIBRON-T/SR
theophylline
TABLET, EXTENDED RELEASE;ORAL087563-001Jun 21, 19834,465,660► subscribe
This preview shows a limited data set
Subscribe for full access, or try a Trial

Export unavailable in trial.
Subscribe for complete access.

« Back to Dashboard

For more information try a trial or see the database preview and plans and pricing

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verifification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.

`abc